News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-01-04-2017
Volume12
Issue 1

Three Novasep Facilities Pass FDA Inspection

Novasep’s three facilities located in France and Germany are free of Form 483.

On Dec. 20, 2016, Novasep announced that three of the company’s manufacturing facilities have passed FDA general inspection process and are free of Form 483. The inspections took place at Novasep’s manufacturing sites in Mourenx and Le Mans, France, and Leverkusen, Germany.

The Le Mans site produces highly potent cytotoxic active pharmaceutical ingredients (HPAPI) and registered advanced intermediates for commercial or clinical development use. The site also provides customers with regulatory and containment evaluation support. It produces paclitaxel, for which Novasep holds a valid drug master file and a European certificate of suitability. The site also offers antibody drug conjugate (ADC) payload production services that will soon be extended to ADC conjugation. Novasep’s site in Leverkusen, Germany handles hazardous chemicals at industrial scale. The site also produces and sells pre-formulated nitroglycerin products for the pharmaceutical market. In each case, the FDA inspection confirmed that commercial APIs produced at each site are suitable for drugs marketed in the United States.

Source: Novasep

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content